PR Newswire Europe - Shire Receives European Union Approval for XAGRID(R) (Anagrelide Hydrochloride).
November 18, 2004 -- BASINGSTOKE, England, November 18 /PRNewswire/ -- Shire Pharmaceuticals Group plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) today announces that it...
PR Newswire UK Disclose - Regulatory Approval.
November 18, 2004 -- Shire Pharmaceuticals Group plc Hampshire International Business Park, Chineham, Basingstoke RG24 8EP UK Tel +44 1256 894000 Fax +44 1256 894708...
Worldwide Biotech - Shire Licenses Agrylin To Kirin Pharmaceutical In Japan
February 1, 2004 -- Shire Pharmaceuticals Group plc (Nasdaq: SHPGY; LSE: SHP; TSX: SHQ), Basingstoke, England, has been signed an agreement with a leading haematology...
